Log In
BCIQ
Print this Print this
 

SQ641

  Manage Alerts
Collapse Summary General Information
Company Sequella Inc.
DescriptionCapuramycin antibiotic
Molecular Target Translocase 1 (TL-1)
Mechanism of ActionTranslocase 1 (TL-1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationTuberculosis
Indication DetailsTreat tuberculosis (TB) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today